Dr. Benjamin Zamanian is a serial biotech entrepreneur and visionary innovator dedicated to advancing next-generation biofabrication and cell-based technologies. As Co-Founder and CEO of Technobiom, he leads the company’s mission to redefine the interface between biology, materials science, and biotechnology. Dr. Zamanian previously co-founded a biotechnology enterprise valued at over $100 million, and his scientific background includes research at Brigham and Women’s Hospital within the Harvard–MIT Health Sciences and Technology (HST) program. His work bridges scientific excellence and business strategy, driving Technobiom’s growth into a multidisciplinary leader in regenerative medicine, tissue engineering, and sustainable bio-manufacturing.
Stay updated on our news and events! Sign up to receive our newsletter.